CYP4 Enzymes As Potential Drug Targets: Focus on Enzyme Multiplicity, Inducers and Inhibitors, and Therapeutic Modulation of 20- Hydroxyeicosatetraenoic Acid (20-HETE) Synthase and Fatty Acid ω- Hydroxylase Activities

Author(s): Katheryne Z. Edson, Allan E. Rettie.

Journal Name: Current Topics in Medicinal Chemistry

Volume 13 , Issue 12 , 2013

Become EABM
Become Reviewer

Abstract:

The Cytochrome P450 4 (CYP4) family of enzymes in humans is comprised of thirteen isozymes that typically catalyze the ω-oxidation of endogenous fatty acids and eicosanoids. Several CYP4 enzymes can biosynthesize 20- hydroxyeicosatetraenoic acid, or 20-HETE, an important signaling eicosanoid involved in regulation of vascular tone and kidney reabsorption. Additionally, accumulation of certain fatty acids is a hallmark of the rare genetic disorders, Refsum disease and X-ALD. Therefore, modulation of CYP4 enzyme activity, either by inhibition or induction, is a potential strategy for drug discovery. Here we review the substrate specificities, sites of expression, genetic regulation, and inhibition by exogenous chemicals of the human CYP4 enzymes, and discuss the targeting of CYP4 enzymes in the development of new treatments for hypertension, stroke, certain cancers and the fatty acid-linked orphan diseases.

Keywords: 20-HETE, CYP4, HET0016, hypertension, stroke, cancer, Refsum disease, X-ALD.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 12
Year: 2013
Page: [1429 - 1440]
Pages: 12
DOI: 10.2174/15680266113139990110
Price: $58

Article Metrics

PDF: 28